When we look at developing countries, the situation of oncology is dramatic.
In Africa, 40% of cancers would be preventable if HPV and hepatitis vaccination were widely practiced.
In sub-Saharan Africa, only 10% of children with retinoblastoma are cured, whereas this is the case for 90% of children with this eye cancer in France;
diagnosis and treatment, however, cost less than 1000 euros.
In terms of diagnosis, advances in modern oncology, anatomopathology, genetics and molecular biology now make it possible to very precisely characterize the type of cancer affecting the patient, and to provide them with personalized treatments.
However, if this precision medicine and these protocols are increasingly common in our Western societies, they are almost non-existent in the majority of low- and middle-income countries.
Half of the world's population is therefore excluded from this progress in…
This article is for subscribers only.
You have 85% left to discover.
Pushing back the limits of science is also freedom.
Keep reading your article for €0.99 for the first month
I ENJOY IT
Already subscribed?
Login